Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Noget Med Ild ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.4% 1.4%   Bankruptcy risk   8.1% 18.5% 25.9% 18.1% 16.4% 10.0% 17.8% 17.8%   Credit score (0-100)   32 8 3 7 10 23 9 9   Credit rating   BB B B B BB BB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 -0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   496 124 -5.9 234 -118 205 0.0 0.0   EBITDA   271 30.7 -5.9 154 -118 128 0.0 0.0   EBIT   271 30.7 -5.9 154 -118 128 0.0 0.0   Pre-tax profit (PTP)   270.8 30.6 -6.1 153.3 -114.6 132.9 0.0 0.0   Net earnings   208.0 23.6 -6.6 118.8 -89.7 103.6 0.0 0.0   Pre-tax profit without non-rec. items   271 30.6 -6.1 153 -115 133 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   211 234 52.5 171 -33.4 70.2 30.2 30.2   Interest-bearing liabilities   0.0 0.0 0.0 0.0 157 65.3 0.0 0.0   Balance sheet total (assets)   444 241 74.4 230 141 243 30.2 30.2   Net Debt   -7.2 -0.7 -74.4 -20.5 145 50.9 -30.2 -30.2     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   496 124 -5.9 234 -118 205 0.0 0.0   Gross profit growth   0.0% -74.9% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employees   0 0 0 1 0 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% -100.0% 0.0% -100.0% 0.0%   Employee expenses   -225.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   444 241 74 230 141 243 30 30   Balance sheet change%   0.0% -45.7% -69.1% 208.4% -38.7% 72.8% -87.6% 0.0%   Added value   496.3 30.7 -5.9 153.8 -118.1 127.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 -1.0 1.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   54.6% 24.7% 100.0% 65.7% 100.0% 62.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   61.0% 9.0% -3.7% 101.2% -55.5% 63.8% 0.0% 0.0%   ROI %   128.7% 13.8% -4.1% 137.5% -68.3% 91.1% 0.0% 0.0%   ROE %   98.8% 10.6% -4.6% 106.1% -57.5% 98.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   47.4% 97.1% 70.6% 74.6% -19.2% 28.9% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -2.7% -2.3% 1,271.1% -13.3% -122.8% 39.8% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% -468.8% 93.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 3.3% 0.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.7 34.3 3.4 3.9 0.8 1.4 0.0 0.0   Current Ratio   1.7 34.3 3.4 3.9 0.8 1.4 0.0 0.0   Cash and cash equivalent   7.2 0.7 74.4 20.5 11.7 14.4 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   155.5 234.1 52.5 171.3 -33.4 70.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 154 0 128 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 154 0 128 0 0   EBIT / employee   0 0 0 154 0 128 0 0   Net earnings / employee   0 0 0 119 0 104 0 0